Health Benefits of Epigallocatechin Gallate and Forskolin for Eye Diseases
Author Information
Author(s): Dario Rusciano
Primary Institution: Fidia Ophthalmics, Catania, Italy
Hypothesis
Can epigallocatechin gallate (EGCG) and forskolin provide therapeutic benefits for retinal diseases like glaucoma?
Conclusion
EGCG and forskolin show promise as treatments for retinal diseases by reducing oxidative stress, inflammation, and intraocular pressure.
Supporting Evidence
- EGCG has significant antioxidant and anti-inflammatory effects that may protect retinal cells.
- Forskolin lowers intraocular pressure, which is critical in managing glaucoma.
- Combining EGCG and forskolin may enhance therapeutic outcomes for retinal diseases.
Takeaway
This study looks at two natural compounds, EGCG from green tea and forskolin from a plant, which might help keep our eyes healthy and prevent diseases like glaucoma.
Methodology
The review consolidates preclinical and clinical studies on the effects of EGCG and forskolin on retinal diseases.
Potential Biases
Potential conflicts of interest due to the author's affiliation with a company involved in ophthalmics.
Limitations
The review highlights the lack of robust clinical studies confirming the therapeutic effects of EGCG and forskolin in humans.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website